Article · 13 Jan 2025
Conference abstract
Quantification of antibiotic influx and efflux in Gram-negative bacteria, impact of outer membrane porins and drug efflux pumps on intracellular antibiotic accumulation
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Antibiotics are a mainstay of modern clinical medicine. However, many bacterial pathogens have acquired multidrug resistance, cause untreatable infections and represent an urgent threat to public health. This situation is especially troubling with respect to Gram-negative pathogens such as Pseudomonas aeruginosa, Acinetobacter baumannii and members of the Enterobacteriaceae family. Meanwhile, the discovery of novel classes of active antibiotics against these pathogens has been impeded by a fundamental lack of understanding of the molecular determinants underlying the intracellular accumulation of small molecules. Gram-negative bacteria are surrounded by two membranes, with the liposaccharide-coated outer membrane that represent a real challenge for small molecules to cross. Small molecules typically translocate through this outer membrane through β-barrel proteins called porins, which form narrow hydrophilic channels lined with charged amino acids. Once inside the cell, these small molecules are susceptible to efflux pumps. Thus, to accumulate in Gramnegative bacteria and reach an active concentration at the vicinity of their intracellular target, small molecules such as antibiotics must cross porins faster than they are pumped out. However, central to the problem of discovering antibiotics that are effective against Gram-negative bacteria is the limited understanding of the physico-chemical properties that enables small-molecule accumulation in Gram-negative bacteria. As a first step to answer this question, we assembled a set of diverse fluoroquinolones and quantified their capacity to accumulate in Escherichia coli. Because porins and efflux pumps represent the main variables that affect small-molecule accumulation, compounds were assessed in accumulation assays using intact cells of isogenic strains and complementary approaches of (micro) spectrofluorimetry and liquid chromatography in tandem with mass spectrometry (LCMS/ MS). From these experiments and subsequent structureto- intracellular accumulation-and-activity relationship (SICAR) studies, we are developing rules that can predict compounds with high accumulation rates in Gram-negative bacteria.
Keywords
Subjects
Infectious DiseasesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Infectious Diseases and Treatment.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Infectious Diseases and Treatment
- SubjectInfectious Diseases
- BylineArticles whose byline prints “Muriel Masi”
- BylineArticles whose byline prints “Julia Vergalli”
- BylineArticles whose byline prints “Estelle Dumont”
- BylineArticles whose byline prints “Jean-Marie Pages”